3623 results for «2221»
3623 results
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
Plan your moves: strategies for valves re-intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Edwards Lifesciences focuses on recognising key elements of valve design that impact ability to host future valves re-interventions, learning how to achieve repeatable implant experiences for the index valve and second valve, and identifying strategies to simplify transcatheter heart valve redo...
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
PCI after TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Through these slides, examine selected cases of percutaneous coronary intervention after TAVI. Explore the case of a successful bailout PCI with en-face view for sinus sequestration after self-expandable TAVI, learn about best management of previous implanted chimney stent during TAVI, and more.
PCR Tokyo Valves 2024 Closing Ceremony
18 Feb 2024 – From PCR Tokyo Valves 2024
The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...
Rapid-fire - LAA closure and plugging
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of left atrium appendage closure and plugging. Discover compelling cases such as the transcatheter closure of a very late atrial septal defect device erosion, learn about the importance of transseptal puncture during left appendage closure, and more....
TAV-in-TAV interventions: a new frontier in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...
Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.
New possibilities in TEER
18 Feb 2024 – From PCR Tokyo Valves 2024
Watch this session to get an overview of a new TEER device, follow the step-by-step procedure related to initial experiences with this device for a Japanese patient with degenerative mitral regurgitation, learn about the latest data from RCT and registries, and follow discussions of challenging TEER...
Mitral and tricuspid intervention
17 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session to discover selected clinical cases regarding complex mitral and tricuspid interventions. Gain insights into phenotypes of secondary tricuspid regurgitation in echocardiography, learn about treatment effectiveness and one-year composite endpoint by clip size of TEER for AFMR, and more!
Rapid-fire - TAVI concomitant with CAD
17 Feb 2024 – From PCR Tokyo Valves 2024
In this series of rapid-fire case submissions, explore cases of TAVI concomitant with coronary artery disease. Learn about innovative procedures such as valve-in-valve chimney stenting, intermediate size THV implantation with coronary protection by chimney stenting, and more!
Rapid-fire - Tricuspid valve interventions in various situations
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore a diverse range of tricuspid valve interventions through various rapid-fire case studies. Learn about a successful TEER of torrential pentacuspid tricuspid regurgitation, gain insight into a percutaneous transcatheter balloon valvuloplasty as a bridge therapy for bioprosthetic tricuspid stenosis, and more!
Complex coronary artery disease: can stents and DCB be complementary?
16 May 2023 – From EuroPCR 2023
DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.
Physiologic guidance and optimisation in multivessel disease
16 May 2023 – From EuroPCR 2023
Follow the case study of this 70-year-old ex-smoker male patient with HTN, dyslipidemia, previous primary PCI to proximal and mid LAD because of anterolateral STEMI, presenting with syncope, and find out, through the debates around his treatment, how to use physiology in 2023.
Rethinking PCI in left main: OCT-guided optimisation
17 May 2023 – From EuroPCR 2023
Discover the transformative role of optical coherence tomography (OCT) in optimizing left main percutaneous coronary intervention (PCI) in this session. Gain insights into how OCT can guide the step-by-step process of left main PCI to achieve optimal results, and explore the crucial parameters of procedural outcome,...
Innovations in device-based treatment for hypertension
17 May 2023 – From EuroPCR 2023
Join this session to explore the latest innovations in device-based treatment for hypertension. Gain a comprehensive understanding of the evidence supporting the efficacy, durability, and safety of radiofrequency renal denervation, learn from renowned experts about the renal denervation procedure and receive valuable insights on patient selection...
Selecting the right first valve to secure lifetime management
17 May 2023 – From EuroPCR 2023
The treatment of young and less at-risk patients clearly shows that their age, life expectancy and risk factors are essential parameters to be taken into account in the choice of TAVI and therefore it is essential to think about future coronary access after TAVI. Watch the...
Third generation OCT (HF-OCT): no more limits to the routine clinical use of intravascular imaging
17 May 2023 – From EuroPCR 2023
Imaging is critical to strategy management. If you want to get a sense of the contributions of HF-OCT in clinical routine, listen to the speakers talk about their real-world experience and learn from their case presentations.
Insights into coronary physiology: pressure microcatheter for clinical decision-making and PCI optimisation
17 May 2023 – From EuroPCR 2023
In this session, analyze the case of a 71-year-old current smoker man with HTN and stable angina CCS II to understand how coronary physiology helps predict what is going to happen after PCI.
